NCI Proposes Inviting Academic Labs To Submit New Therapies For Development
In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm
Research Funding: 30 Groups Sign Letter For Double NCI Budget
Tobacco Regulation: ACS Advocates Giving FDA Full Authority Over Tobacco
Funding Opportunities: March 1 Deadline For ACS Fellowships; Program Announcements
NIH On R29 Phase-Out; Grant Review Appeals Process Changed
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program









